Cargando…

COVID-19 and hydroxychloroquine: Let the available data speak for themselves

Detalles Bibliográficos
Autores principales:	Paliani, Ugo, Cardona, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier B.V. on behalf of European Federation of Internal Medicine. 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373053/ https://www.ncbi.nlm.nih.gov/pubmed/32709544 http://dx.doi.org/10.1016/j.ejim.2020.07.017

Ejemplares similares

COVID-19 and hydroxychloroquine: Is the wonder drug failing?
por: Paliani, Ugo, et al.
Publicado: (2020)

Is COVID-19 a Real Incentive for Flu Vaccination? Let the Numbers Speak for Themselves
por: Di Pumpo, Marcello, et al.
Publicado: (2021)

Letting the data speak for themselves: a fully Bayesian approach to transcriptome assembly
por: Schulz, Marcel H
Publicado: (2014)

Thrombotic microangiopathy: COVID-19 or hydroxychloroquine?
por: Hasbal, Nuri Baris
Publicado: (2020)

Hydroxychloroquine, TTP, COVID-19, and SLE
por: Sookaromdee, Pathum, et al.
Publicado: (2021)

Long COVID-19/post-COVID condition in children: do we all speak the same language?
por: Garazzino, Silvia, et al.
Publicado: (2023)

Balanced evaluation of preliminary data on a candidate COVID-19 hydroxychloroquine treatment
por: Seligmann, Hervé
Publicado: (2021)

The Hon. Sydney Holland's Latest Circular: "The Facts Speak for the Themselves"
Publicado: (1905)

Antimalarials (chloroquine and hydroxychloroquine) in the COVID-19 pandemic()
por: Jáuregui, Edwin
Publicado: (2021)

Nephrotoxicity of Chloroquine and Hydroxychloroquine in COVID-19 Patients
por: Mahmoudi, Javad, et al.
Publicado: (2021)

Letter to the editor: The effect of hydroxychloroquine on COVID-19
por: Demir, Canan, et al.
Publicado: (2022)

Analysis of hydroxychloroquine prescriptions for COVID‐19 in Japan
por: Watari, Takashi, et al.
Publicado: (2023)

Data Don’t Speak for Themselves. Alternative Explanations for Long-Term Use of Psychiatric Drugs
por: Troisi, Alfonso
Publicado: (2020)

Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19
por: Gevers, S., et al.
Publicado: (2020)

Psychiatric implications of the use of hydroxychloroquine in COVID-19 patients
por: Rani, Seema, et al.
Publicado: (2020)

Reduced steatosis and weight as a result of specific diets or the dietitian themselves
por: Trivedi, Hirsh D., et al.
Publicado: (2021)

Role of endothelial dysfunction in the thrombotic complications of COVID-19 patients
por: Falcinelli, Emanuela, et al.
Publicado: (2021)

Communicating with conscious mechanically ventilated critically ill patients: let them speak with deflated cuff and an in-line speaking valve!
por: Egbers, Peter H., et al.
Publicado: (2017)

Palliative care for COVID-19: Let Us be Prepared…
por: Pruthi, Megha, et al.
Publicado: (2020)

“Let me choose my COVID-19 vaccine”
por: Dal-Ré, Rafael, et al.
Publicado: (2021)

Reply to: “Reduced steatosis and weight as a result of specific diets or the dietitian themselves”
por: Holmer, Magnus, et al.
Publicado: (2021)

Crowdsourcing Your Sales: Let Your Customers Sell Themselves (and Others)
por: Libert, Barry
Publicado: (2010)

The significance of correct dosing of hydroxychloroquine in clinical trials of COVID-19
por: Sadasivam, Balakrishnan, et al.
Publicado: (2020)

Psychiatric adverse events with hydroxychloroquine during COVID-19 pandemic
por: Emmanuel, Stip, et al.
Publicado: (2020)

Hydroxychloroquine for prophylaxis and treatment of COVID-19 in health-care workers
por: Simova, I., et al.
Publicado: (2020)

Can we use hydroxychloroquine to treat COVID-19 now?
por: Chen, Jun, et al.
Publicado: (2021)

Sharing experience: Hydroxychloroquine in preexposure prophylaxis against COVID-19
por: Kulkarni, Chanda, et al.
Publicado: (2021)

Hydroxychloroquine: is there a role in long COVID?
por: Wang, Samuel S. Y., et al.
Publicado: (2023)

Reply: More details on microbiome profile and IVF, would allow readers to judge for themselves
por: Koedooder, R, et al.
Publicado: (2021)

Let's build the psychological immunity to fight against COVID-19
por: Gupta, Tanu, et al.
Publicado: (2020)

Letter to the Editor: Acharya Prafulla Chandra Ray, Hydroxychloroquine and COVID-19
por: Gupta, Nikhil, et al.
Publicado: (2020)

Effectiveness of hydroxychloroquine in COVID-19 disease: A done and dusted deal?
por: d’Arminio Monforte, Antonella, et al.
Publicado: (2020)

Hydroxychloroquine in COVID-19: Taking care of statistics to take care of patients
por: Brito-Azevedo, Anderson
Publicado: (2020)

Use of hydroxychloroquine and interferon alpha-2b for the prophylaxis of COVID-19
por: Yang, Alexander, et al.
Publicado: (2020)

Hydroxychloroquine and chloroquine for COVID-19: psychiatric aspects of patient safety considerations
por: Biswas, Partha Sarathi, et al.
Publicado: (2020)

Inhaled hydroxychloroquine to improve efficacy and reduce harm in the treatment of COVID-19
por: Kavanagh, Oisín, et al.
Publicado: (2020)

A sound approach: Hydroxychloroquine reduces mortality in severe COVID-19
por: Zervos, Marcus, et al.
Publicado: (2020)

Numbers don’t speak for themselves: strategies of using numbers in public policy discourse
por: Jablonka, Eva, et al.
Publicado: (2021)

Letting the Brain Speak for Itself
por: Werner, Gerhard
Publicado: (2011)

Clinical efficacy and safety profile of hydroxychloroquine and azithromycin against COVID-19
por: Gautret, Philippe, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1vsqs66qgl23t0a60et0j40mkk